TICKVALE
>⌘K
NYSE · CIK 0001156039 · HOSPITAL & MEDICAL SERVICE PLANS

ELEVANCE HEALTH, INC.

ELV chart by TradingView
P/E 17.0xP/B 1.9xP/SALES 0.4xEV/EBITDA 15.1xFCF YIELD 7.46%

PRICE HISTORY

LIVE · NYSE
ELV chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$199B
EBITDA
$8.7B
FREE CASH FLOW
$3.2B
EPS
$25.21
GROSS MARGIN
89.36%
ROIC
8.54%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

17.0x
+15%
LATEST · Q2 FY26
17.0xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
11.4x22.3x

P / SALES (TTM)

0.4x
+4%
LATEST · Q2 FY26
0.4xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.3x0.8x

P / BOOK

1.9x
+38%
LATEST · Q2 FY26
1.9xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
1.4x3.4x

EV / EBITDA (TTM)

15.1x
+60%
LATEST · Q2 FY26
15.1xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
8.9x18.1x

EV / REVENUE (TTM)

0.5x
-6%
LATEST · Q2 FY26
0.5xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.4x1.0x

FCF YIELD (TTM)

7.46%
-2.6pp
LATEST · Q2 FY26
7.46%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.65%14.83%

DIVIDEND YIELD (TTM)

-0.8pp
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.95%2.05%

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$50.5B
+136%
LATEST · Q2 FY26
50.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

$1.9B
+66%
LATEST · Q2 FY26
1.9BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$1.5B
+137%
LATEST · Q2 FY26
1.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$6.71
+191%
LATEST · Q2 FY26
6.71Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

1.40%
-6.1pp
LATEST · Q2 FY26
1.40%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.05%20.09%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

3.22%
-0.5pp
LATEST · Q2 FY26
3.22%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-7.73%18.03%

RETURN ON CAPITAL

7.55%
+1.4pp
LATEST · Q2 FY26
7.55%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
6.11%12.27%

RETURN ON EQUITY (TTM)

11.06%
+1.8pp
LATEST · Q2 FY26
11.06%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
9.22%17.46%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN89.12%
OPERATING MARGIN3.49%
NET MARGIN2.90%
FCF MARGIN3.22%
110.7778.4546.1313.82-18.50GROSSOPERNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$1.6B
+103%
LATEST · Q2 FY26
1.6BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.1B
+79%
LATEST · Q2 FY26
0.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.3B
+75%
LATEST · Q2 FY26
0.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

0.22B
-19%
LATEST · Q2 FY26
0.22BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

$1.72
+165%
LATEST · Q2 FY26
1.72Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$10.2B
+302%
LATEST · Q2 FY26
10.2BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

$31.0B
+105%
LATEST · Q2 FY26
31.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

4.5x
+44%
LATEST · Q2 FY26
4.5xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.3x4.5x

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 94.66%INSIDERS 0.19%OTHER / RETAIL 5.16%2,103 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.9.17%19.9M$7.84B-2.5%
Vanguard Capital Management LLC6.61%14.3M$5.65BNEW
State Street Corporation4.74%10.3M$4.06B-0.5%
Wellington Management Group, LLP3.79%8.2M$3.24B-0.7%
Vanguard Portfolio Management LLC2.93%6.4M$2.51BNEW
Sanders Capital, LLC2.72%5.9M$2.32B+2.5%
Geode Capital Management, LLC2.39%5.2M$2.05B+1.3%
Artisan Partners Limited Partnership2.36%5.1M$2.02B+1.9%
Invesco Ltd.2.22%4.8M$1.90B+23.4%
Harris Associates L.P.2.21%4.8M$1.89B+0.0%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.